These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 16394481

  • 41. [Tuberculoid leprosy ("Single skin lesion")].
    Rieker J, Ritzmann S, Talhari C, Homey B, Ruzicka T, Bruch-Gerharz D.
    Hautarzt; 2005 Oct; 56(10):973-5. PubMed ID: 16142494
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
    Ji B.
    Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):391-2. PubMed ID: 9934368
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Sural nerve biopsy in leprosy patients after varying periods of treatment: histopathological and bacteriological findings on light microscopy.
    Haimanot RT, Mshana RN, McDougall AC, Andersen JG.
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):163-70. PubMed ID: 6539309
    [Abstract] [Full Text] [Related]

  • 48. Higher incidence of viable Mycobacterium leprae within the nerve as compared to skin among multibacillary leprosy patients released from multidrug therapy.
    Shetty VP, Suchitra K, Uplekar MW, Antia NH.
    Lepr Rev; 1997 Jun; 68(2):131-8. PubMed ID: 9217352
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of leprosy patients with 1 to 5 skin lesions with relevance to their grouping into paucibacillary or multibacillary disease.
    Rao PN, Pratap D, Ramana Reddy AV, Sujai S.
    Indian J Dermatol Venereol Leprol; 2006 Jun; 72(3):207-10. PubMed ID: 16766835
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
    Pattyn S, Grillone S.
    Lepr Rev; 2002 Sep; 73(3):245-7. PubMed ID: 12449889
    [Abstract] [Full Text] [Related]

  • 53. Chemotherapy of leprosy.
    Biswas SK, WHO.
    J Indian Med Assoc; 2004 Dec; 102(12):695-6, 698. PubMed ID: 15871354
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
    Jain M, Singh N, Bhatia A, Arora VK.
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
    [Abstract] [Full Text] [Related]

  • 58. Response of thickened nerve trunks and skin lesions of leprosy patients to MDT.
    Porichha D, Rao AK, Nehemaiah E, Mishra MC.
    Indian J Lepr; 2011 Jun; 83(1):31-5. PubMed ID: 21638981
    [Abstract] [Full Text] [Related]

  • 59. Analysis of gene probes and gene amplification techniques for diagnosis and monitoring of treatment in childhood leprosy.
    Kamal R, Dayal R, Katoch VM, Katoch K.
    Lepr Rev; 2006 Jun; 77(2):141-6. PubMed ID: 16895070
    [Abstract] [Full Text] [Related]

  • 60. Histopathological lesions of apparently normal skin in leprosy patients.
    Rashed HA, Mearag I, Saleh NM, Saied A.
    J Egypt Soc Parasitol; 2009 Dec; 39(3):933-42. PubMed ID: 20120756
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.